A353190 Stock Overview
Researches, develops, manufactures, and distributes health supplements in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Hurum Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,040.00 |
| 52 Week High | ₩1,423.00 |
| 52 Week Low | ₩970.00 |
| Beta | 0.63 |
| 1 Month Change | -3.52% |
| 3 Month Change | -7.56% |
| 1 Year Change | -23.30% |
| 3 Year Change | -63.83% |
| 5 Year Change | n/a |
| Change since IPO | -48.13% |
Recent News & Updates
Shareholder Returns
| A353190 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | -0.5% | 3.3% | -1.7% |
| 1Y | -23.3% | 32.1% | 0.6% |
Return vs Industry: A353190 underperformed the KR Personal Products industry which returned 32.1% over the past year.
Return vs Market: A353190 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
| A353190 volatility | |
|---|---|
| A353190 Average Weekly Movement | 4.5% |
| Personal Products Industry Average Movement | 6.6% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.3% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A353190 has not had significant price volatility in the past 3 months.
Volatility Over Time: A353190's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 134 | Jin Seok Kim | hurumcorp.com |
Hurum Co., Ltd. researches, develops, manufactures, and distributes health supplements in South Korea and internationally. The company offers lactobacillus under the TrueLAC brand name; and yogurt and biological health supplements. It also operates frozen yogurt franchise store under the Yogurberry name.
Hurum Co., Ltd. Fundamentals Summary
| A353190 fundamental statistics | |
|---|---|
| Market cap | ₩40.95b |
| Earnings (TTM) | ₩2.73b |
| Revenue (TTM) | ₩94.66b |
15.0x
P/E Ratio0.4x
P/S RatioIs A353190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A353190 income statement (TTM) | |
|---|---|
| Revenue | ₩94.66b |
| Cost of Revenue | ₩59.63b |
| Gross Profit | ₩35.02b |
| Other Expenses | ₩32.29b |
| Earnings | ₩2.73b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 69.41 |
| Gross Margin | 37.00% |
| Net Profit Margin | 2.89% |
| Debt/Equity Ratio | 37.1% |
How did A353190 perform over the long term?
See historical performance and comparison